Results 1 to 10 of about 75,748 (340)

NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients [PDF]

open access: yesBMC Geriatrics
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is useful to predict adverse outcomes. Change in NT-proBNP level may provide additional actionable risk assessment information. This study aimed to determine the association of change in NT-
Jinling Ma, Ang Li, Suyan Bian
doaj   +2 more sources

Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD [PDF]

open access: yesIndian Pacing and Electrophysiology Journal
Aims: Plasma NT-proBNP is an established marker of heart failure. Previous studies suggested urinary NT-proBNP has potential as marker of chronic heart failure as well. The objective of this study was to compare urinary NT-proBNP to plasma NT-proBNP in a
Benedikt Seither   +14 more
doaj   +2 more sources

Characterization of NT-proBNP in Human Urine [PDF]

open access: bronzeClinical Chemistry, 2009
Abstract Background: Urine amino-terminal probrain natriuretic peptide (NT-proBNP) concentrations may exclude the presence of heart failure and provide insight into renal clearance mechanisms for human NT-proBNP. We characterized the molecular forms of urine NT-proBNP detected by immunoassay.
Suetonia C. Palmer   +3 more
openalex   +4 more sources

Periprocedural changes in natriuretic peptide levels and clinical outcome after transcatheter mitral valve repair

open access: yesESC Heart Failure, 2021
Aims This multicentre study investigated the association of periprocedural changes in the levels of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) with clinical outcomes after transcatheter edge‐to‐edge mitral valve repair (TMVR).
Tetsu Tanaka   +12 more
doaj   +1 more source

Effect of body mass index on N-terminal pro-brain natriuretic peptide values in patients with heart failure

open access: yesThe Egyptian Heart Journal, 2023
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker used for the diagnosis of heart failure. There is a relationship between NT-proBNP levels and body mass index (BMI). The study aimed to explore the impact of BMI on NT-proBNP
Tuan Ha Manh, Duong Do Anh, Tung Le Viet
doaj   +1 more source

Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes [PDF]

open access: yes, 2012
<p>Background: Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression.
,   +7 more
core   +11 more sources

The Ratio of NT-proBNP to CysC1.53 Predicts Heart Failure in Patients With Chronic Kidney Disease

open access: yesFrontiers in Cardiovascular Medicine, 2021
Background: The N-terminal pro B type natriuretic peptide (NT-proBNP) is important for prognosis of heart failure in patients with chronic kidney disease (CKD).
Sheng Wang   +10 more
doaj   +1 more source

NT-proBNP

open access: yesJournal of the American College of Cardiology, 2016
BACKGROUND: Pulmonary hypertension (PH) is a serious complication to interstitial lung disease (ILD) and has a poor prognosis. PH is often diagnosed by screening with echocardiography followed by right heart catheterisation. A previous study has shown that a value of NT-pro-brain natriuretic peptide (NT-proBNP) <95 ng/l could be used to rule out PH ...
Andersen, Charlotte   +3 more
openaire   +3 more sources

Impact of socioeconomic and cardiovascular risk factors on the effect of genetic variants associated with NT-proBNP

open access: yesScientific Reports, 2022
N-terminal prohormone of brain natriuretic peptide (NT-proBNP) is an established biomarker for diagnosis of heart failure. The study aims to explore whether known cardiovascular risk factors, including education and income as indicators of socioeconomic ...
Emanuel Matusch   +7 more
doaj   +1 more source

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme

open access: yesESC Heart Failure, 2021
Aims Guidelines support the role of B‐type natriuretic peptide (BNP) and amino‐terminal pro‐BNP (NT‐proBNP) for risk stratification of patients in programmes to prevent heart failure (HF).
Claire Sweeney   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy